Coronary heart disease (CHD) is the leading cause of morbidity and mortality in patients with diabetes. Asymptomatic CHD in these patients is elusive and carries a poor prognosis given the fact that an unheralded acute myocardial infarction or sudden cardiac death frequently constitutes its first presentation. Because effective screening for asymptomatic patients with type 2 diabetes for both the presence and severity of CHD is intuitively appealing, we have summarized the utility and prognostic value of various diagnostic modalities (both functionally and anatomically) in enhancing risk stratification and leading to improved and more aggressive management of the risk factors. There exist some evidence and recommendations for screening of asymptomatic persons with diabetes using certain modalities. More research is needed to define potential subsets of patients with diabetes who may benefit from additional testing for asymptomatic CHD.
机构:
Technion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, IsraelTechnion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
Aronson, Doron
Edelman, Elazer R.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Brigham & Womens Hosp,Dept Med,Cardiovasc Div, MIT,Inst Med Sci & Engn, Boston, MA 02115 USATechnion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
机构:
Technion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, IsraelTechnion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
Aronson, Doron
Edelman, Elazer R.
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Brigham & Womens Hosp, MIT, Cardiovasc Div,Dept Med,Inst Med Sci & Engn,Med S, Boston, MA 02115 USATechnion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel